Literature DB >> 4194541

Amantadine versus L-2 dopa and amatadine plus L-dopa.

C Fieschi, M Nardini, M Casacchia, M E Tedone, M Reitano, E Robotti.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4194541     DOI: 10.1016/s0140-6736(70)92742-x

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  10 in total

1.  The comparative value of amantadine and levodopa.

Authors:  V Dallos; K Heathfield; P Stone; F Allen
Journal:  Postgrad Med J       Date:  1972-06       Impact factor: 2.401

Review 2.  Levodopa: a review of its pharmacological properties and therapeutic use with particular reference to Parkinsonism.

Authors:  R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1971       Impact factor: 9.546

3.  Interactions of L-dopa and amantadine in patients with Parkinsonism.

Authors:  B Cox; G Danta; H Schnieden; G M Yuill
Journal:  J Neurol Neurosurg Psychiatry       Date:  1973-06       Impact factor: 10.154

4.  Amantadine actions on acetylcholine and GABA in striatum and substantia nigra of rat in relation to behavioral changes.

Authors:  I J Bak; R Hassler; J S Kim; K Kataoka
Journal:  J Neural Transm       Date:  1972       Impact factor: 3.575

5.  On the effect of amantadine on monoamines and their metabolites in the brain and cerebrospinal fluid.

Authors:  U K Rinne; V Sonninen; M Hyyppä
Journal:  Experientia       Date:  1972-01-15

6.  Treatment for Parkinsonism, other than levodopa.

Authors: 
Journal:  Br Med J       Date:  1972-03-18

Review 7.  Clinical pharmacokinetics of anti-parkinsonian drugs.

Authors:  J M Cedarbaum
Journal:  Clin Pharmacokinet       Date:  1987-09       Impact factor: 6.447

8.  Amantadine-HCl (Symmetrel) in the management of Parkinson's disease: a double-blind cross-over study.

Authors:  A Barbeau; H Mars; M I Botez; M Joubert
Journal:  Can Med Assoc J       Date:  1971-07-10       Impact factor: 8.262

9.  Effect of amantadine on drug-induced parkisonism: relationship between plasma levels and effect.

Authors:  G M Pacifici; M Nardini; P Ferrari; R Latini; C Fieschi; P L Morselli
Journal:  Br J Clin Pharmacol       Date:  1976-10       Impact factor: 4.335

Review 10.  Amantadine in Parkinson's disease.

Authors:  N Crosby; K H Deane; C E Clarke
Journal:  Cochrane Database Syst Rev       Date:  2003
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.